Targeting HER2 Alterations in Non-small Cell Lung Cancer: Therapeutic Breakthrough and Challenges

The authors summarize recent therapeutic advances in targeting human epidermal growth factor receptor 2 (HER2) alterations in NSCLC and highlight the future perspectives of these patient populations.